ArticleOncotarget2016

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression.

Chiara Ciardiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.